Ambeed.cn

首页 / 动物造模剂 / 免疫与炎症疾病模型 / 肝脏炎症模型 / Lithocholic Acid/石胆酸

Lithocholic Acid/石胆酸 {[allProObj[0].p_purity_real_show]}

货号:A746553 同义名: 3α-Hydroxy-5β-cholanic acid; LCA

Lithocholic Acid是一种次级胆汁酸,作为 FXR 拮抗剂和 PXR/SXR 激动剂,用于研究肿瘤发生和脂肪吸收。

Lithocholic Acid/石胆酸 化学结构 CAS号:434-13-9
Lithocholic Acid/石胆酸 化学结构
CAS号:434-13-9
Lithocholic Acid/石胆酸 3D分子结构
CAS号:434-13-9
Lithocholic Acid/石胆酸 化学结构 CAS号:434-13-9
Lithocholic Acid/石胆酸 3D分子结构 CAS号:434-13-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Lithocholic Acid/石胆酸 纯度/质量文件 产品仅供科研

货号:A746553 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Lithocholic Acid/石胆酸 生物活性

描述 Antipyrine (Phenazone) serves as both an antipyretic and an analgesic. It is commonly utilized as a probe agent for studying the metabolism of oxidative agents, playing a significant role in assessing hepatic oxidative capacity[1].[2].
体内研究

In dietary studies, lithocholic acid at a concentration of 0.6% in the diet over a period of 7 days leads to increased mRNA levels of TGFB1, TGFBR1, and TGFBR2 in the liver of male C57BL/6 mice, activates SMAD3, and results in biliary injury[4].

Additionally, an intraperitoneal dose of 125 mg/kg administered twice daily for four days results in liver damage in male C57BL/6 mice, marked by elevated levels of AST, ALT, and ALP[2].

体外研究

Lithocholic acid inhibits FXR activation induced by CDCA and GW4064, with IC50 values of 0.7 μM and 1.4 μM, respectively[5].

Lithocholic acid also suppresses GW4064-induced BSEP expression at concentrations of 10-30 μM over 24 hours in HepG2 cells[5].

Furthermore, lithocholic acid inhibits the proliferation of various neuroblastoma cell lines (BE(2)-M17, SK-n-SH, SK-n-MCIXC, and Lan-1) in a dose-dependent manner, up to 500 μM[3].

Lithocholic Acid/石胆酸 细胞实验

Cell Line
Concentration Treated Time Description References
CD4+ T cells 100 μM 48 hours To assess the ability of bacteria to convert LCA to 3-oxoLCA and isoLCA. Results showed that multiple bacterial strains could convert LCA to 3-oxoLCA and isoLCA. Nature. 2022 Mar;603(7903):907-912.
Barrett’s cell lines (CP-C and CP-D) 15 μM 1 hour To assess the effect of LCA and ATRA alone or in combination on p21 mRNA expression. Results showed that combined treatment with LCA and ATRA led to a threefold increase in p21 mRNA expression, indicating that LCA can augment the effect of local RA to stimulate RA signalling. Gut. 2007 Jul;56(7):906-17.
IEC-6 cells 20 μM 5 days To evaluate the effect of 7-keto-LCA on intestinal epithelial cells, results showed that 7-keto-LCA had anti-apoptotic and proliferative effects. Cell Host Microbe. 2024 Feb 14;32(2):191-208.e9.
HT29 cells 20 μM 5 days To evaluate the effect of 7-keto-LCA on intestinal stem cell function, results showed that 7-keto-LCA promoted the proliferation and differentiation of intestinal stem cells. Cell Host Microbe. 2024 Feb 14;32(2):191-208.e9.

Lithocholic Acid/石胆酸 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice GF mice Oral 0.3% w/w Once daily for 7 days To assess the effect of isoLCA on TH17 cell differentiation. Results showed that isoLCA significantly reduced TH17 cell differentiation. Nature. 2022 Mar;603(7903):907-912.
C57BL/6 Il10–/– mice C. jejuni infection model Oral gavage 30 mg/kg body weight Daily for 12 days To evaluate the effect of lithocholic acid on C. jejuni-induced colitis. Results showed that lithocholic acid did not alleviate colitis. Gastroenterology. 2018 May;154(6):1751-1763.e2
Mice C57BL/6NCr mice and Fxr-null mice Dietary supplementation 0.6% LCA-supplemented diet 7 consecutive days To investigate the effect of LCA on phospholipid and sphingolipid metabolism, results showed that LCA significantly decreased serum LPC and SM levels, increased hepatic ceramide levels, and altered related gene expression through TGF-β-SMAD3 signaling. Hepatology. 2011 Apr;53(4):1282-93.
C57BL/6J mice Aspirin-induced intestinal injury model Oral gavage 50 mg/kg/d Once daily for 2 weeks To evaluate the protective effect of 7-keto-LCA on aspirin-induced intestinal injury, results showed that 7-keto-LCA significantly alleviated intestinal injury and promoted the recovery of intestinal barrier function. Cell Host Microbe. 2024 Feb 14;32(2):191-208.e9.

Lithocholic Acid/石胆酸 参考文献

[1]Jenkins, D.J., et al., Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med, 1993. 329(1): p. 21-6.

[2]Yang R, et al. Metabolomic analysis of cholestatic liver damage in mice. Food Chem Toxicol. 2018 Jul 14;120:253-260.

[3]Goldberg, A.A., et al., Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget, 2011. 2(10): p. 761-82.

[4]Matsubara, T., et al., TGF-beta-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury. J Lipid Res, 2012. 53(12): p. 2698-707.

[5]Yu J, et al. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem. 2002 Aug 30;277(35):31441-7.

Lithocholic Acid/石胆酸 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.66mL

0.53mL

0.27mL

13.28mL

2.66mL

1.33mL

26.56mL

5.31mL

2.66mL

Lithocholic Acid/石胆酸 技术信息

CAS号434-13-9
分子式C24H40O3
分子量 376.57
SMILES Code C[C@H](CCC(O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
MDL No. MFCD00003682
别名 3α-Hydroxy-5β-cholanic acid; LCA; Lithocolic acid; NSC 683770; Lithocholate; 3α-hydroxy Cholanic Acid
运输蓝冰
InChI Key SMEROWZSTRWXGI-HVATVPOCSA-N
Pubchem ID 9903
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 250 mg/mL(663.88 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

无水乙醇: 8 mg/mL(21.24 mM),配合低频超声,并水浴加热至45℃助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
方案 四
方案 五
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。